Saving Residual Renal Function Among Haemodialysis Patients Receiving Irbesartan
NCT00791830 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 82
Last updated 2013-01-08
Summary
Angiotensin II receptor blockers (ARB) are known to preserve kidney function among patients with kidney diseases and reduced renal function, but not among haemodialysis patients.
Haemodialysis patients often lose residual renal function after initiating dialysis leading to worsened quality of life, increased morbidity and mortality.
In this study an ARB is investigated in a double blind, randomised, parallel group, placebo controlled manner to see, if this ARB can save residual renal function among haemodialysis patients. Potential cardiovascular benefits of the treatment are also addressed.
Conditions
- Kidney Failure, Chronic
Interventions
- DRUG
-
Irbesartan
Tablets, 300 mg \* 1 daily, 1 year
- DRUG
-
Placebo matching irbesartan 150 mg
Tablets, 300 mg \* 1 daily, 1 year
Sponsors & Collaborators
-
University of Aarhus
lead OTHER
Principal Investigators
-
Bente Jespersen, MD, DrMedSc · Department of Nephrology, Aarhus University Hospital, Skejby, Denmark
-
Erik Sloth, MD, DrMedSc · Department of Anaesthesiology and Intensive Care, Aarhus University Hospital, Skejby, Denmark
-
Jens Kristian D Jensen, MD, PhD · Department of Nephrology, Aarhus University Hospital, Skejby, Denmark
-
Krista D Kjærgaard, MD, PhD · Department of Nephrology, Aarhus University Hospital, Skejby, Denmark
-
Christian D Peters, MD · Department of Nephrology, Aarhus University Hospital, Skejby, Denmark
-
Charlotte Strandhave, MD · Department of Nephrology, Aalborg University Hospital, Denmark
-
Ida N Tietze, MD, PhD · Department of Internal Medicine, Region Hospital Viborg, Denmark
-
Marija K Novosel, MD · Department of Internal Medicine, Region Hospital Fredericia, Denmark
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-04-30
- Primary Completion
- 2013-01-31
- Completion
- 2013-01-31
Countries
- Denmark
Study Locations
More Related Trials
-
Heparin-Free Chronic HemoDialysis Assessment
NCT06224140 ·Status: RECRUITING ·Phase: NA
-
Does Incremental Initiation of Haemodialysis Preserve Native Kidney Function?
NCT03418181 ·Status: UNKNOWN ·Phase: NA
-
Tolerance of "on Line" Hemodiafiltration in Chronic Renal Failure Patients
NCT01327391 ·Status: COMPLETED ·Phase: PHASE4
-
Chinese Medicine on Deferring Dialysis Initiation
NCT02194946 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Uremic Toxin Removal and Hemodynamics in Long-hour Hemodialysis and Hemodiafiltration
NCT01328119 ·Status: COMPLETED ·Phase: NA
-
Treatment of Resistant Hypertension by Renal Sympathetic Denervation in Patients Undergoing Dialysis Therapy
NCT01881035 ·Status: TERMINATED ·Phase: NA
-
Twice vs Thrice Weekly Incident Hemodialysis in Elderly Patients
NCT06141798 ·Status: RECRUITING ·Phase: NA
-
The Hemodynamic Effects During Sustained Low-efficiency Dialysis Versus Continuous Veno-venous Hemofiltration for Patients With Intracranial Hypertension in a Cross Over Study
NCT01781585 ·Status: WITHDRAWN
-
Chronic Pain in Patients in Hemodialysis
NCT06311240 ·Status: RECRUITING
-
Hemodialysis-Induced Renal Perfusion Decline: Unraveling the Pathophysiological Mechanisms Linking Intradialytic Circulatory Stress to Residual Renal Function Loss
NCT07003828 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of a Pathway on the Evolution of Renal Function in Patients With Advanced Chronic Kidney Disease
NCT06219798 ·Status: RECRUITING
-
Association of Survival in Impact of Ultrafiltration Rates in Hemodialysis Patients
NCT03471299 ·Status: COMPLETED
-
Survival Study in Patients Undergoing On-line Hemodiafiltration
NCT00694031 ·Status: COMPLETED ·Phase: PHASE4
-
Is Myocardial Stunning Induced by Continuous Renal Replacement Therapy a Reality in Critically Ill Patients?
NCT05209230 ·Status: COMPLETED ·Phase: NA
-
Association Between Dose Dialysis by Kt and Mortality
NCT01932853 ·Status: COMPLETED
-
Effect of Dialysate Temperature on Haemodynamic Stability and Haemodialysis Efficiency
NCT00221598 ·Status: COMPLETED ·Phase: NA
-
Reducing Arrhythmia in Dialysis by Adjusting the Rx Electrolytes/Ultrafiltration, Study B
NCT03519360 ·Status: WITHDRAWN ·Phase: NA
-
HFR Cartridge and Inflammation
NCT01865773 ·Status: COMPLETED ·Phase: NA
-
Anticoagulation in Chronic Hemodialysis Patients Versus Hemodialyzer Fiber Patency, Bleedings and Quality of Life
NCT05365542 ·Status: COMPLETED
-
Safety and Efficacy of Intermittent Renal Replacement Therapy Using CITRASATE in Critically-ill Patients
NCT05313230 ·Status: UNKNOWN
-
Functionality of Albumin in the Context of Hemodialysis
NCT06561191 ·Status: RECRUITING ·Phase: NA
-
An Observational Study of Pruritus Amongst Hemodialysis Patients
NCT00715260 ·Status: UNKNOWN
-
HepZero:Heparin Free Dialysis With Evodial
NCT01318486 ·Status: COMPLETED ·Phase: NA
-
Safety of Remdesivir Treatment in COVID-19 Patients Requiring Hemodialysis
NCT04854837 ·Status: COMPLETED
-
Implantable Loop Recorder in Hemodialysis Patients
NCT01252823 ·Status: COMPLETED ·Phase: NA